KEGG   DRUG: Sofosbuvir, velpatasvir and voxilaprevirHelp
Entry
D10900            Mixture   Drug                                   

Name
Sofosbuvir, velpatasvir and voxilaprevir;
Vosevi (TN)
Product
Component
Sofosbuvir [DR:D10366], Velpatasvir [DR:D10806], Voxilaprevir [DR:D10899]
Remark
ATC code: J05AP56
Product: D10900<US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C virus infection [DS:H00413]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP56 Sofosbuvir, velpatasvir and voxilaprevir
      D10900  Sofosbuvir, velpatasvir and voxilaprevir <US>
Antiinfectives [br08350.html]
 Antivirals
  D10900
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10900
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10900
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10900
BRITE hierarchy
Other DBs
PubChem: 340650304
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system